Biodesix and Addario Lung Cancer Medical Institute initiate study to predict overall survival using checkpoint immunotherapy for lung cancer patients
BOULDER and SAN CARLOS, Calif. -- Addario Lung Cancer Medical Institute (ALCMI) and Biodesix, Inc. today announced they will begin an observational study to prospectively evaluate the clinical... Read More
Tuesday September 1, 2020 0 comments
Biodesix to provide COVID-19 testing for CSU campus
BOULDER -- Biodesix, Inc. announced it will provide COVID-19 ddPCR diagnostic testing for Colorado State University as students return to campus for the fall term, which begins Aug. 24. “The... Read More
Thursday August 13, 2020 0 comments
Biodesix appoints Franchi, Massarany to company's board of directors
BOULDER -- Biodesix, Inc. announced the appointment of Jean Franchi and Hany Massarany to the company’s board of directors. Ms. Franchi has more than 30 years of biotechnology and life... Read More
Wednesday July 22, 2020 0 comments
Biodesix pipeline test identifies patients likely to respond to immune checkpoint inhibitors
BOULDER -- Biodesix, Inc. announced publication of research findings on a diagnostic test capable of generating valuable data to help guide the treatment of patients with advanced non-small cell... Read More
Monday July 20, 2020 0 comments
Biodesix collaborates with Bio-Rad to launch test to detect COVID-19 antibodies
BOULDER -- Biodesix, Inc . announced it has collaborated with California-based Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to launch a blood-based immunoassay-based test that identifies... Read More
Wednesday May 20, 2020 0 comments
Biodesix begins COVID-19 testing, can process 1,000 tests per day in Boulder
BOULDER -- Biodesix, Inc. announced it began SARS-CoV-2 Droplet Digital PCR (ddPCR) testing for the virus that causes COVID-19 and will immediately submit for Emergency Use Authorization from the... Read More
Wednesday April 8, 2020 0 comments
Biodesix strengthens lung nodule testing strategy with Nodify CDT test
BOULDER -- Biodesix, Inc. announced it is extending its blood-based testing portfolio with the release of the Nodify CDT TM test, designed to help physicians identify patients with lung nodules at... Read More
Wednesday March 4, 2020 0 comments
Biodesix partners with Merck, Pfizer on lung cancer proteomic test
BOULDER -- Biodesix, Inc. announced the next phase of the companys biomarker development program with Germany-based Merck and New York-based Pfizer Inc. The companies have completed initial... Read More
Wednesday February 12, 2020 0 comments
- 1
- 2
IN Sponsors
Browse
Entrepreneurial by Nature
